ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today…
Junshi Biosciences Announces Toripalimabs Approval in Singapore
SHANGHAI, March 26, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd…
Novartis receives third FDA approval for oral Fabhalta (iptacopan) the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first…
VINSSEN Receives Type Approval for Maritime Fuel Cell Stack from RINA
SEOUL, South Korea, March 21, 2025 /PRNewswire/ -- VINSSEN, a maritime decarbonization…
ZEISS VISUMAX 800 with SMILE pro software receives approval in China
Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment,…
MediBeacon Transdermal GFR System receives device approval in China; Peer-reviewed articles on MediBeacon technology published
Transdermal GFR System (TGFR) is a first-in-kind product for point of care…
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old,…
Nxu Announces Shareholder Approval of Merger with Verde Bioresins
MESA, Ariz., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Nxu, Inc., (NASDAQ: NXU)…
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
– GOMEKLI is the first and only medicine approved for both adults…
SpringWorks Therapeutics Announces FDA Approval of GOMEKLI (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
– GOMEKLI is the first and only medicine approved for both adults…